Derek Hicks, MBA'02

Executive Vice President and Chief Business Officer, Intellia Therapeutics

Derek Hicks is the chief business officer for Intellia, a leading clinical-stage genome editing company developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.

Derek brings more than 25 years of combined business leadership and biotechnology experience to Intellia. As chief business officer at Intellia, Derek is responsible for overall corporate strategy, portfolio planning, and developing new business and strategic partnerships.

Prior to Intellia, Derek served as head of business development at Spark Therapeutics. While at Spark, he was responsible for business development strategy, search and evaluation, licensing, and key partnership activities. Before this role, Derek spent 18 years at Pfizer in a variety of business and corporate development roles culminating with his position as vice president of Corporate Development, World-Wide Business Development.

Derek holds his Bachelor of Science and Master of Science degrees in mechanical engineering from the University of Connecticut and an MBA from Indiana University’s Kelley School of Business. 

For his extraordinary investment in the Kelley School and its alumni network, Derek Hicks, MBA'02, was presented the Volunteer Leadership Award 2023 by the Kelley School of Business.